Octagen Corporation is a clinical research site located in Blue Bell, Pennsylvania, United States 19422.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Octagen Corporation has participated in 1 clinical trials.
Therapeutic areas: Hemophilia A.
Sponsors: Octagen Corporation.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Octagen Corporation has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Octagen Corporation has 1 clinical trials on record. Their work covers Hemophilia A.
Octagen Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.